327 related articles for article (PubMed ID: 16362986)
21. Recombinant DNA virus vectors for vaccination.
Moss B
Semin Immunol; 1990 Sep; 2(5):317-27. PubMed ID: 2134016
[TBL] [Abstract][Full Text] [Related]
22. Engineering of DNA vaccines using molecular adjuvant plasmids.
Sin JI; Kim J; Chattergoon M; Ayyavoo V; McCallus D; Ugen KE; Boyer JD; Weiner DB
Dev Biol (Basel); 2000; 104():187-98. PubMed ID: 11713819
[TBL] [Abstract][Full Text] [Related]
23. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
Durántez M; López-Vázquez AB; de Cerio AL; Huarte E; Casares N; Prieto J; Borrás-Cuesta F; Lasarte JJ; Sarobe P
Scand J Immunol; 2009 Feb; 69(2):80-9. PubMed ID: 19144076
[TBL] [Abstract][Full Text] [Related]
24. DNA vaccines against enteric infections.
Herrmann JE
Vaccine; 2006 May; 24(18):3705-8. PubMed ID: 16095769
[TBL] [Abstract][Full Text] [Related]
25. DNA vaccines for biodefence.
Garmory HS; Perkins SD; Phillpotts RJ; Titball RW
Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877
[TBL] [Abstract][Full Text] [Related]
26. Viral vectors for use in the development of biodefense vaccines.
Lee JS; Hadjipanayis AG; Parker MD
Adv Drug Deliv Rev; 2005 Jun; 57(9):1293-314. PubMed ID: 15935875
[TBL] [Abstract][Full Text] [Related]
27. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.
Chong SY; Egan MA; Kutzler MA; Megati S; Masood A; Roopchard V; Garcia-Hand D; Montefiori DC; Quiroz J; Rosati M; Schadeck EB; Boyer JD; Pavlakis GN; Weiner DB; Sidhu M; Eldridge JH; Israel ZR
Vaccine; 2007 Jun; 25(26):4967-82. PubMed ID: 17335943
[TBL] [Abstract][Full Text] [Related]
28. Use of viral vectors for the development of vaccines.
Liniger M; Zuniga A; Naim HY
Expert Rev Vaccines; 2007 Apr; 6(2):255-66. PubMed ID: 17408374
[TBL] [Abstract][Full Text] [Related]
29. DNA vaccine design.
Brandsma JL
Methods Mol Med; 2006; 127():3-10. PubMed ID: 16988442
[TBL] [Abstract][Full Text] [Related]
30. Salmonella-based vaccines for infectious diseases.
Kwon YM; Cox MM; Calhoun LN
Expert Rev Vaccines; 2007 Apr; 6(2):147-52. PubMed ID: 17408365
[TBL] [Abstract][Full Text] [Related]
31. [New technologies for vaccine development].
Leclerc C
Med Sci (Paris); 2007 Apr; 23(4):386-90. PubMed ID: 17433228
[TBL] [Abstract][Full Text] [Related]
32. Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice.
Guo L; Wang J; Zhou H; Si H; Wang M; Song J; Han B; Shu Y; Ren L; Qu J; Hung T
Vaccine; 2008 Jan; 26(4):460-8. PubMed ID: 18160189
[TBL] [Abstract][Full Text] [Related]
33. Replicase-based DNA vaccines for allergy treatment.
Scheiblhofer S; Weiss R; Gabler M; Leitner WW; Thalhamer J
Methods Mol Med; 2006; 127():221-35. PubMed ID: 16988457
[TBL] [Abstract][Full Text] [Related]
34. DNA vaccines: capacity to induce auto-immunity and tolerance.
Klinman DM; Takeshita F; Kamstrup S; Takeshita S; Ishii K; Ichino M; Yamada H
Dev Biol (Basel); 2000; 104():45-51. PubMed ID: 11713823
[TBL] [Abstract][Full Text] [Related]
35. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
[TBL] [Abstract][Full Text] [Related]
36. Strategies of constructing recombinant vaccines.
Sałamaszyńska-Guz A; Klimuszko D
Pol J Vet Sci; 2009; 12(1):133-9. PubMed ID: 19459451
[TBL] [Abstract][Full Text] [Related]
37. Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.
Shinoda K; Xin KQ; Kojima Y; Saha S; Okuda K; Okuda K
Clin Immunol; 2006 Apr; 119(1):32-7. PubMed ID: 16458074
[TBL] [Abstract][Full Text] [Related]
38. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.
Xing Z; Charters TJ
Expert Rev Vaccines; 2007 Aug; 6(4):539-46. PubMed ID: 17669008
[TBL] [Abstract][Full Text] [Related]
39. Use of attenuated bacteria as delivery vectors for DNA vaccines.
Daudel D; Weidinger G; Spreng S
Expert Rev Vaccines; 2007 Feb; 6(1):97-110. PubMed ID: 17280482
[TBL] [Abstract][Full Text] [Related]
40. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.
Zhao HP; Sun JF; Li N; Sun Y; Wang Y; Qiu HJ
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):158-66. PubMed ID: 19411115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
